Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome

BACKGROUND: Paediatric acute respiratory distress syndrome (PARDS) is a manifestation of severe, life-threatening lung injury necessitating mechanical ventilation with mortality rates ranging up to 40–50%. Neuromuscular blockade agents (NMBAs) may be considered to prevent patient self-inflicted lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudolph, Michelle W., Slager, Sjoerdtje, Burgerhof, Johannes G. M., van Woensel, Job B.M., Alffenaar, Jan-Willem C., Wösten - van Asperen, Roelie M., de Hoog, Matthijs, IJland, Marloes M., Kneyber, Martin C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802263/
https://www.ncbi.nlm.nih.gov/pubmed/35101098
http://dx.doi.org/10.1186/s13063-021-05927-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802263/
https://www.ncbi.nlm.nih.gov/pubmed/35101098
http://dx.doi.org/10.1186/s13063-021-05927-w

Ejemplares similares